The ability of 2-amlno-4-hydroy-7-[dibydroxylpropyl-(L-erythro)-5,6,7,8-tetrahydropterinJ ("7-tetrahydroblopterin" or Hyperphenylalaninemia is an abnormality characteristic of a series of diseases that result from an inability to catalyze the first step in the catabolism of phenylalanine-namely, its conversion to tyrosine (1). The most common cause of this abnormality is the absence of active phenylalanine hydroxylase due to a defect in the gene coding for this enzyme (2, 3). Variant forms of this disease have been reported that are caused by genetic defects in either the biosynthesis of the essential pterin cofactor tetrahydrobiopterin (BH4) or its enzymatic regeneration (4). Since BH4 is required for catecholamine and serotonin biosynthesis by tyrosine hydroxylase and tryptophan hydroxylase, respectively (4), patients with these other forms of hyperphenylalaninemia also have a deficiency of biogenic amine neurotransmitters.Recently, several patients have been described with a mild form of hyperphenylalaninemia, who have elevated urinary levels of an isomer of BH4, 2-amino-4-hydroxy-7-[1,2-dihydroxypropyl)-(L-erythro)-5,6,7,8-tetrahydropteridine] ("7-tetrahydrobiopterin" or 7-BH4),* and somewhat decreased levels of BH4 (5). It has been suggested (6, 7) that the accumulation of abnormal amounts of 7-BH4 might be the result of an alteration of the gene coding for 4a-hydroxytetrahydrobiopterin dehydratase (6,7). This enzyme catalyzes the dehydration of 4a-hydroxytetrahydrobiopterin (4a-carbinolamine), the form of the pterin that is initially released from the aromatic amino acid hydroxylases after the BH4-dependent hydroxylation of their respective substrates (7-9). In vitro, 4a-carbinolamine dehydrates at a rapid rate even in the absence of the dehydratase, but a small percentage of the 4a-carbinolamine rearranges to form the 7-isomer (6, 7). Thus the dehydratase plays the dual role of catalyzing the dehydration and preventing the isomerization ofthe pterin cofactor (7).To date, the cause of the observed mild hyperphenylalaninemia in children who excrete 7-BH4 remains unclear. Among the possible reasons for this abnormality are either that the reaction catalyzed by the dehydratase becomes rate-limiting due to the absence of the enzyme or that 7-BH4 itself in some way impairs the phenylalanine hydroxylation reaction. One possible mechanism for such impairment became apparent when we showed that the oxidation of 7-BH4 by phenylalanine hydroxylase in the presence of phenylalanine is 85-90%o uncoupled from the hydroxylation of the substrate (10). In this report we demonstrate an additional mechanism by which 7-BH4 might impair phenylalanine hydroxylase activity; i.e., 7-BH4 is a potent inhibitor of this reaction. Furthermore, we have examined the effect of 7-BH4 on the reactions catalyzed by tyrosine hydroxylase and tryptophan hydroxylase and have found that although these reactions are inhibited by this pterin in vitro, the inhibition is manifested only at very high concentrations of 7-BH4.MATERLS AND METH...